Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected patients.
The report details the trend, potential and market size of Colorectal Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Colorectal Cancer Drugsmarket, defines the market attractiveness level of Colorectal Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Colorectal Cancer Drugs industry, describes the types of Colorectal Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Colorectal Cancer Drugs market and the development prospects and opportunities of Colorectal Cancer Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Colorectal Cancer Drugs market in Chapter 13.
By Player:
Taiho Pharmaceutical
Regeneron
Sanofi
Mologen
Boehringer Ingelheim
Array BioPharma
Elli Lilly
AB Science
Vaccinogen
Bristol-Myers Squibb
Amgen
Sumitomo Dainippon
Roch
Bayer
Hutchison MediPharma
By Type:
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators
By End-User:
Radiotherapy
Chemotherapy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Colorectal Cancer Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Colorectal Cancer Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Colorectal Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Colorectal Cancer Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Colorectal Cancer Drugs Market Analysis and Outlook to 2022
-
7.1 Global Colorectal Cancer Drugs Consumption (2017-2022)
-
7.2 United States Colorectal Cancer Drugs Consumption (2017-2022)
-
7.3 Europe Colorectal Cancer Drugs Consumption (2017-2022)
-
7.4 China Colorectal Cancer Drugs Consumption (2017-2022)
-
7.5 Japan Colorectal Cancer Drugs Consumption (2017-2022)
-
7.6 India Colorectal Cancer Drugs Consumption (2017-2022)
-
7.7 South Korea Colorectal Cancer Drugs Consumption (2017-2022)
8 Region and Country-wise Colorectal Cancer Drugs Market Analysis and Outlook to 2028
-
8.1 Global Colorectal Cancer Drugs Consumption Forecast (2022-2028)
-
8.2 United States Colorectal Cancer Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Colorectal Cancer Drugs Consumption Forecast (2022-2028)
-
8.4 China Colorectal Cancer Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Colorectal Cancer Drugs Consumption Forecast (2022-2028)
-
8.6 India Colorectal Cancer Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Colorectal Cancer Drugs Consumption Forecast (2022-2028)
9 Global Colorectal Cancer Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Colorectal Cancer Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global BRAF or MEK Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Tyrosine Kinase (TKI) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
9.2 Global Colorectal Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Radiotherapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)
10 Global Colorectal Cancer Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Colorectal Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global BRAF or MEK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Tyrosine Kinase (TKI) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Colorectal Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
11 Global Colorectal Cancer Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Colorectal Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Colorectal Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Colorectal Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Colorectal Cancer Drugs Market Competitive Analysis
-
14.1 Taiho Pharmaceutical
-
14.1.1 Taiho Pharmaceutical Company Details
-
14.1.2 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Taiho Pharmaceutical Colorectal Cancer Drugs Product and Service
-
14.2 Regeneron
-
14.2.1 Regeneron Company Details
-
14.2.2 Regeneron Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Regeneron Colorectal Cancer Drugs Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Colorectal Cancer Drugs Product and Service
-
14.4 Mologen
-
14.4.1 Mologen Company Details
-
14.4.2 Mologen Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mologen Colorectal Cancer Drugs Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Product and Service
-
14.6 Array BioPharma
-
14.6.1 Array BioPharma Company Details
-
14.6.2 Array BioPharma Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Array BioPharma Colorectal Cancer Drugs Product and Service
-
14.7 Elli Lilly
-
14.7.1 Elli Lilly Company Details
-
14.7.2 Elli Lilly Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Elli Lilly Colorectal Cancer Drugs Product and Service
-
14.8 AB Science
-
14.8.1 AB Science Company Details
-
14.8.2 AB Science Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AB Science Colorectal Cancer Drugs Product and Service
-
14.9 Vaccinogen
-
14.9.1 Vaccinogen Company Details
-
14.9.2 Vaccinogen Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Vaccinogen Colorectal Cancer Drugs Product and Service
-
14.10 Bristol-Myers Squibb
-
14.10.1 Bristol-Myers Squibb Company Details
-
14.10.2 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bristol-Myers Squibb Colorectal Cancer Drugs Product and Service
-
14.11 Amgen
-
14.11.1 Amgen Company Details
-
14.11.2 Amgen Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Amgen Colorectal Cancer Drugs Product and Service
-
14.12 Sumitomo Dainippon
-
14.12.1 Sumitomo Dainippon Company Details
-
14.12.2 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Sumitomo Dainippon Colorectal Cancer Drugs Product and Service
-
14.13 Roch
-
14.13.1 Roch Company Details
-
14.13.2 Roch Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Roch Colorectal Cancer Drugs Product and Service
-
14.14 Bayer
-
14.14.1 Bayer Company Details
-
14.14.2 Bayer Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Bayer Colorectal Cancer Drugs Product and Service
-
14.15 Hutchison MediPharma
-
14.15.1 Hutchison MediPharma Company Details
-
14.15.2 Hutchison MediPharma Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Hutchison MediPharma Colorectal Cancer Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Colorectal Cancer Drugs
-
Figure Colorectal Cancer Drugs Picture
-
Table Global Colorectal Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Colorectal Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Colorectal Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Colorectal Cancer Drugs Consumption by Country (2017-2022)
-
Figure United States Colorectal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Colorectal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Colorectal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Colorectal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Colorectal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Colorectal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Colorectal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Colorectal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Colorectal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Colorectal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Colorectal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Colorectal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global BRAF or MEK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Tyrosine Kinase (TKI) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
Figure Global Radiotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BRAF or MEK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tyrosine Kinase (TKI) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Colorectal Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Colorectal Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Taiho Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taiho Pharmaceutical Colorectal Cancer Drugs Product and Service
-
Table Regeneron (Foundation Year, Company Profile and etc.)
-
Table Regeneron Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Colorectal Cancer Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Colorectal Cancer Drugs Product and Service
-
Table Mologen (Foundation Year, Company Profile and etc.)
-
Table Mologen Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mologen Colorectal Cancer Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Colorectal Cancer Drugs Product and Service
-
Table Array BioPharma (Foundation Year, Company Profile and etc.)
-
Table Array BioPharma Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Array BioPharma Colorectal Cancer Drugs Product and Service
-
Table Elli Lilly (Foundation Year, Company Profile and etc.)
-
Table Elli Lilly Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Elli Lilly Colorectal Cancer Drugs Product and Service
-
Table AB Science (Foundation Year, Company Profile and etc.)
-
Table AB Science Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AB Science Colorectal Cancer Drugs Product and Service
-
Table Vaccinogen (Foundation Year, Company Profile and etc.)
-
Table Vaccinogen Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vaccinogen Colorectal Cancer Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Colorectal Cancer Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Colorectal Cancer Drugs Product and Service
-
Table Sumitomo Dainippon (Foundation Year, Company Profile and etc.)
-
Table Sumitomo Dainippon Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sumitomo Dainippon Colorectal Cancer Drugs Product and Service
-
Table Roch (Foundation Year, Company Profile and etc.)
-
Table Roch Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roch Colorectal Cancer Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Colorectal Cancer Drugs Product and Service
-
Table Hutchison MediPharma (Foundation Year, Company Profile and etc.)
-
Table Hutchison MediPharma Colorectal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hutchison MediPharma Colorectal Cancer Drugs Product and Service
-
